Objective A systematic review and meta-analysis of randomized controlled trials (RCTs) were performed to understand the effectiveness of medication adherence (MA) interventions among Chinese patients with hypertension. Methods A literature search was conducted with three English databases (PubMed, Web of Science and Embase) and three Chinese databases (China National Knowledge Infrastructure, Wanfang and VIP Database for Chinese Technical Periodicals) for the period from 1970 to October 2017. Only both RCTs with a minimum of 10 participants in each intervention group and Chinese patients with hypertension as participants were included. A random-effects model was applied to calculate pooled effect sizes with 95% CI. Subgroup analysis was conducted to identify potential sources of heterogeneity from duration of intervention, type of intervener, methods of intervention and sites of intervention. Funnel plots and Egger's test were used to evaluate for publication bias. Key findings A total of 48 studies met criteria for the meta-analysis, including 14 568 participants, testing 57 independent comparisons. Overall, the effect size revealed that interventions significantly improved MA (pooled relative risk = 1.59, 95% CI: 1.43 to 1.78; pooled Cohen's d = 1.42, 95% CI: 0.976 to 1.876). Interventions were found to significantly reduce blood pressure (BP) (systolic BP: Cohen's d = À0.85, 95% CI: À1.11 to À0.60 and diastolic BP: Cohen's d = À0.73, 95% CI: À1.00 to À0.46). Longer duration of intervention gave better effectiveness. Physician as interventionist, regular follow-up visits and interventions conducted at a hospital were associated with better effectiveness. Conclusion Adherence interventions improve MA and reduce uncontrolled BP among Chinese patients with hypertension. In the future, investigators should adopt a skill set to address the problem of poor MA.
Introduction
Hypertension is a critical public health problem worldwide and is considered the most dangerous factor for cardiovascular disease, cerebrovascular disease and renal diseases. In China, prevalence of hypertension has been rising, with rates increasing from 18.8% in 2002 to 25 .2% in 2012.
[1]
The health disparity is particularly on hypertension control. The Chinese population has a lower prevalence of controlled hypertension (15%) than does the American population (55.7%). [2, 3] Hypertensive patients' blood pressure (BP) needs be controlled, to decrease the incidence of adverse sequelae. There is an association between poor medication adherence (MA) and inadequate BP control. Nearly 75% of non-adherent patients fail to achieve optimal BP. [4] Adherence to prescribed antihypertensive agents can reduce the risk of stroke by 35-40% and myocardial infarction by 20-25% according to the survey by Chobanian et al. [5] and Collins et al. [6] However, non-adherence to antihypertensive therapy is increasingly prevalent, causing approximately 125 000 deaths per year. [7] Factor analysis reveals that poor MA may be related to the symptomless nature of the condition, the long duration of therapy, adverse drug reactions, complicated drug regimens, the lack of understanding about hypertension management, expensive drugs and the challenges to individual patients' health beliefs. [8, 9] Some authorities point out that 80% adherence is probably sufficient for most drugs. [10, 11] Chinese hypertensive patients display very poor MA, with reported rates ranging from 40% to 65.8%. [12] [13] [14] [15] Due to the large population base and the rapid increase in better living conditions in China, interventions to improve patients' MA are more important now than ever. In recent years, using intervention measures and experience of developed countries for reference, Chinese researchers have conducted some interventions to improve patients' MA and clinical outcomes. However, conclusions from epidemiological studies about the intervention effectiveness differ widely.
Therefore, a systematic review and meta-analysis were conducted to summarize evidence for effectiveness of MA interventions among Chinese patients with hypertension based on available RCTs. Heterogeneity and publication bias were quantified and evaluated independently.
Methods
Standardized systematic review and meta-analysis were adopted to synthesize the effectiveness for interventions to improve the MA among Chinese patients with hypertension. Findings are reported following the PRISMA guidelines.
Inclusion criteria
The inclusion criteria were as follows (PICOs): (1) population: Chinese adults, male or female, aged more than 18 years with a diagnosis of hypertension in each intervention group; (2) intervention: any intervention targeted at MA, with a minimum of 10 patients per group; (3) control: inactive control groups or only basic health education; (4) outcome: MA outcome reported; and (5) study design: only RCTs were considered. Exclusion criteria included case reports, editorials, reviews, letters and comments. There were no exclusions based on publication dates. Only papers written in English or Chinese were included.
Information sources and search strategies
Multiple search strategies were performed to reduce the risk of retrieval bias. An information retriever and two investigators conducted literature searches using three English databases (PubMed, Web of Science and Embase) and three Chinese databases (China National Knowledge Infrastructure, Wanfang and VIP Database for Chinese Technical Periodicals) for the period from 1970 to October 2017 (MA behavior has changed a little since 1970 [16, 17] ). Retrieved titles, abstracts and then full texts were screened in duplicate against the inclusion and exclusion criteria to identify potential papers. To search the English databases, research terms included medication adherence OR patient compliance OR compliant OR compliance OR adherent OR adherence OR noncompliant OR noncompliance OR nonadherence OR nonadherent OR hypertension OR antihypertensive OR high blood pressure OR hypertensive, pharmaceutical services OR pharmaceutical care OR pharmacist education OR counsel OR medication guideline OR intervention OR China OR Chinese. Chinese databases were searched using subject terms medication adherence, compliance and hypertension. Search strategies for each database are included as Appendix S1.
Data extraction
To reduce the risk of bias, two investigators independently extracted data from eligible studies and entered the data into an Excel spreadsheet (Microsoft Excel 2007), which included the following: first author's name, year of publication, location (province), mean age of study population, total sample size, number of patients in both intervention and control groups' components and duration of intervention in each study, the number of patients with good MA in both intervention and control groups between both baseline and outcome, and mean systolic blood pressure (SBP) and diastolic blood pressure (DBP) values. Any disagreements were resolved by consensus or by the third investigator.
Risk of bias
Multiple search strategies were conducted among English databases and Chinese databases to avoid publication bias. The presence of publication bias was detected using funnel plots visually and Egger's test statistically. [18] Two investigators also assessed the quality of eligible articles independently using Jadad scale. [19] The assessment standard was based on the following: randomization, double blind, failure to follow-up and cancellation of investigation. Scoring was according to a 0-5 scale: ≤2 scores were regarded as lower quality, and ≥3 scores were regarded as high quality.
Statistical analysis
Stata 11.0 (Stata Corporation, College Station, Texas, USA). and EndNote X7 (Thomson Reuters Corporation, Manhattan, New York, USA) were used to calculate effect size and to manage citation data, respectively. All eligible studies were grouped and described according to whether they reported continuous data (mean AE standard deviation) or dichotomous data (good MA or poor MA). Standardized mean difference effect size (Cohen's d) and relative risk value (RR) were calculated for each comparison of those MA outcomes as continuous data and dichotomous data, respectively. [20] To facilitate the merging of data, days, weeks and years are uniformly converted into months. A forest plot was constructed to reflect the effect size and 95% confidence interval, calculating the Isquared and Q statistic to determine the heterogeneity among all eligible studies (I 2 = 25%, 50%, 75% delivering corresponding information of low, moderate and high levels of heterogeneity, respectively). [21] Heterogeneity was anticipated due to its universality in behavioural research. [22] Random-effects models were chosen due to the expected heterogeneity that I 2 was >50%. [21] Subgroup analyses were conducted to explore the effect of intervention duration, intervention components, deliverer of intervention and site of intervention.
Results
A total of 7135 potentially relevant studies were identified by the search strategy. After initial screening, 3590 duplicates were excluded. Then, 1679 and 1244 studies were excluded by reading titles and abstracts, respectively. Six hundred and twenty-two potentially eligible studies were assessed for eligibility. Five hundred and seventy-four studies did not meet inclusion criteria. Finally, 57 separate comparisons from 48 eligible studies were identified, including 12 studies written in English and 36 studies in Chinese. Eligible studies included a total of 9227 intervention participants and 8909 control participants with an overall total of 14 568 participants (see PRISMA chart attached as Figure S1 ). Table 1 provides an overview of the 48 included studies. Nine studies reported two comparisons [23, 24, 27, 30, 32, 33, 42, 61, 67] (designated as different follow-up duration and intervention intensity). A total of 14 568 participants from 20 provinces or regions were included. Ten studies were carried out in municipalities (Beijing, Shanghai and Tianjin), two in special administrative region of China (Hong Kong) and 36 in provinces. Three types of professional (pharmacist, physician, nurse) delivered the interventions at three different sites (home, community, hospital). Four different intervention components were identified including medication education, self-monitoring of BP, reminders and regular follow-up visits. More detailed information on intervention characteristics is included in Table S1 . All eligible studies were published between 2003 and 2017, and 45 studies were published in 2010 or later. Thirtynine studies reported the mean age of patients, with the median age of 62.2 years. Additional details are displayed in Table 1 . Max, maximum; Mdn, median; Min, minimum; N, number of studies; Q, quartile. 
Study characteristics

Quantitative synthesis
The results of the pooled analysis are displayed in Table 2 . We chose the random-effects model to calculate pooled effect size due to the high heterogeneity among comparisons. In the analysis of dichotomous data, a total of 39 intervention versus control comparisons were calculated to pool the effect size. The RR value was 1.59 (95% CI: 1.43 to 1.78; P < 0.01, Figure 1 ). We calculated effect size for 27 intervention pre-versus post-comparisons and 27 control pre-and post-comparisons, for which the RR values were 1.80 (95% CI: 1.46 to 2.21; P < 0.01) and 1.05 (95% CI: 0.902 to 1.22; P = 0.54), respectively. In the analysis of continuous data, the ES (Cohen's d) across the 18 intervention versus control comparisons was 1.42 (95% CI: 0.98 to 1.88; P < 0.01, Figure 2 ). For 15
Figure 1 Forest plot of included two-group studies, intervention versus control groups (dichotomous data). [Colour figure can be viewed at wileyonlinelibrary.com]
intervention group and 14 control group pre-versus post-comparisons, the Cohen's d was 1.57 (95% CI: 0.97 to 2.16; P < 0.01) and 0.231 (95% CI: À0.14 to 0.603; P = 0.47), respectively. The change of BP was also analysed to assess the effectiveness of intervention. A total of 31 comparisons of SBP and 30 comparisons of DBP were included in the analysis. For intervention groups versus control groups of SBP, the overall ES (Cohen's d) was À0.85 (À1.109 to À0.60; P < 0.01) and the overall ES (Cohen's d) of DBP was À0.73 (95% CI: À1.00 to À0.46; P < 0.01).
All types of comparisons showed significant heterogeneity ( Table 2 ). The I 2 ranged from 88.6% to 97.4%.
Subgroup analysis
The ESs were influenced by the duration of the intervention (P < 0.001). Longer duration gave a larger ES for <6 months versus 6, 7, 8, 9, 10 and 11 months versus 12 months and above (0.843 versus 1.754 versus 3.03) ( Table 3) . Studies with physician, pharmacist and nurse interventionists reported significantly greater ESs than without physician, pharmacist and nurse interventionists. However, physicians were more effective (2.80) than pharmacist (1.95) or nurse (1.79).
Adopting education compared to no education had a greater ES (Cohen's d = 1.51 compared to Cohen's d = 0.92) (P = 0.55). Self-monitoring of BP and setting a reminder each gave a lower ES than when these were not done (0.58 versus 1.71, P = 0.02; 0.18 versus 1.70, P < 0.001, respectively). In addition, the difference in ES for interventionists' regular follow-up visits and absence of follow-up visits was statistically significant (1.77 versus 0.38, P < 0.001).
There was a significant difference when interventions were conducted at home versus not at home (1.82 versus 0.50, P < 0.001). Non-significant variables included interventions delivered in community and interventions delivered in hospital. 
Publication bias
Funnel plots were conducted to assess the potential publication bias of four main comparisons, which showed some evidence of publication bias among intervention versus control comparisons (dichotomous and continuous data) with very large positive ESs. The finding was confirmed by Egger's test (P < 0.001, P = 0.001). No evidence of publication bias was showed in funnel plots of BP intervention versus control comparisons, and Egger's test was not significant (SBP: P = 0.432, DBP: P = 0.788). In addition, other comparisons also were detected using Egger's test, which showed higher risk of publication bias among intervention group pre-versus post-comparisons (dichotomous data: P < 0.001, continuous data: P = 0.024) and lower risk of publication bias among control group pre-versus post-comparisons (dichotomous data: P = 0.101, continuous data: P = 0.664). Details are displayed in Table 2 and 
Discussion
Findings from this meta-analysis suggest that interventions to improve MA among Chinese patients with hypertension are effective and may lead to less uncontrolled BP. Intervention effectiveness increases with the duration of intervention and regular follow-up visits, as well as the intervention being delivered by a physician.
This review is a comprehensive analysis of MA intervention effectiveness for hypertensive patients in China. Multiple search strategies were conducted using English and Chinese databases to identify as larger studies as possible. However, there are several limitations of this metaanalysis. Although the search strategies were constructed systematically, it is possible that some eligible articles and unpublished articles may have been missed. Dichotomous and continuous outcomes were analysed separately, which might have introduced bias. Interventions of different intensities were included in this analysis, which may increase the risk of publication bias. Some studies did not report relevant results; for example, partial studies have no baseline data of BP. This raises the possibility of information bias. Finally, there is heterogeneity and publication bias across some stratified analyses. Among 48 eligible studies, including 57 comparisons, 12 control versus intervention comparisons reported that changes had no statistical significance, suggesting disparate outcomes and implying publication bias. The characteristic of intervention of these studies mainly revealed the following points: (1) relevant research started relatively recently, but the attention of researchers grew gradually. (2) These interventions were mainly conducted in economically developed regions, with poorer performance in underdeveloped areas. (3) The content of interventions was more restricted than developed countries.
Of the overall ESs, positive effectiveness was found for interventions to improve MA among Chinese patients with hypertension. This effect size was stronger than that reported by recent foreign meta-analysis [71] (which reported multiple racial studies worldwide). Our metaanalysis also suggests that interventions to improve MA among Chinese patients with hypertension can effectively decrease uncontrolled SBP and DBP. However, these results differ from those obtained in a meta-analysis of pharmacist interventions by Machado et al., [72] which reported that only SBP can be affected by intervention, but the studies included in this meta-analysis did not focus on improving only MA. The comprehensive results reveal that adherence to prescribed antihypertensive agents is an important factor (probably more than this one) for achieving optimal BP. The same result also was reported by the systematic review of effectiveness of pharmacist interventions by Morgado et al. [73] There were several interesting findings among our subgroup analysis results: larger ES was found with increasing duration of intervention. However, a recent metaanalysis by Ruppar et al. [74] on assessing the effectiveness of MA interventions in heart failure patients showed no significant relationship with the length of intervention effectiveness. A possible explanation is that longer intervention duration can change medication habits. In addition, physicians were more effective in improving MA than pharmacists or nurses. This result contrasts with another meta-analysis by Ruppar et al. [75] showing that pharmacists play more effective role than others for hypertensive black adults. Clinical pharmacists from hospitals were the majority of all pharmacists as providers of delivery interventions. However, the profession of clinical pharmacist in China has been established for a relatively short time compared with developed countries and is not well recognized by patients. [76] Even most medication guidelines and health education were delivered by physician in hospital, which resulted in lower patients' acceptance to clinical pharmacists' interventions possibly.
Adopting education to improve the rate of MA was found to have no significantly larger ES than no education. Assuredly, medication education is widely practised and has been shown to be effective. [16] However, Chinese educational level is very low, with 31.57% of the population only receiving primary education or below, [77] and the situation is worse among patients with hypertension. Therefore, an appropriate approach of medication education needs to be tested to address the issue. The ESs for self-monitoring of signs and setting reminders designed as intervention components were found to be significantly lower than interventions lacking these. Further behavioural research needs to consider the needs of patients of varying levels of education.
Interventions delivered at home were more effective to improve patients' MA. Interventions delivered at home may reduce the patient's money and time costs, which can improve patient and family receptivity to interventions. The considerable ES for interventions delivered at hospital was larger than that for home or community, but there was no statistical significance, which may be related to not enough number of comparisons.
Conclusion
The meta-analysis showed that interventions can improve MA and reduce uncontrolled BP among Chinese patients with hypertension. Self-monitoring of BP, setting reminders and longer duration of intervention were components of interventions likely to be associated with better MA.
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